US Stock MarketDetailed Quotes
VRTX Vertex Pharmaceuticals
- 475.980
- +0.900+0.19%
Close Oct 31 16:00 ET
- 471.020
- -4.960-1.04%
Post 16:16 ET
122.85BMarket Cap-240393P/E (TTM)
477.695High468.980Low1.37MVolume471.580Open475.080Pre Close650.00MTurnover0.53%Turnover Ratio34.27P/E (Static)258.10MShares510.63552wk High8.31P/B122.48BFloat Cap341.90052wk Low--Dividend TTM257.33MShs Float510.635Historical High--Div YieldTTM1.83%Amplitude7.250Historical Low475.397Avg Price1Lot Size
About Vertex Pharmaceuticals Company
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.
Company Profile
SymbolVRTX
Company NameVertex Pharmaceuticals
Listing DateJul 4, 1991
Issue Price13.75
Founded1989
CEODr. Reshma Kewalramani, M.D.
MarketNASDAQ
Employees5400
Fiscal Year Ends12-31
Address50 Northern Avenue
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-617-341-6100
Websitehttp://www.vrtx.com
Company Executives
- Name
- Position
- Salary
- Dr. Reshma Kewalramani, M.D.
- Director, President and Chief Executive Officer
- 20.59M
- Jonathan Biller
- Executive Vice President and Chief Legal Officer
- --
- Kristen Ambrose
- Senior Vice President and Chief Accounting Officer
- --
- Stuart A. Arbuckle
- Executive Vice President and Chief Operating Officer
- 9.00M
- Dr. E Morrow Atkinson, III, PhD
- Executive Vice President, Chief Technical Operations Officer, Head of Biopharmaceutical Science and Manufacturing Operations
- --
- Amit K. Sachdev, J.D.
- Executive Vice President and Chief Patient and External Affairs Officer
- --
- Dr. Ourania Tatsis
- Executive Vice President and Chief Regulatory and Quality Officer
- --
- Charles F. Wagner, Jr
- Executive Vice President and Chief Financial Officer
- 7.37M
- Carmen Bozic
- Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer
- --
- Dr. David Altshuler
- Executive Vice President, Global Research and Chief Scientific Officer
- 6.54M
- Dr. Jeffrey M Leiden, PhD
- Executive Chairman of the Board
- 6.60M
- Lloyd A. Carney
- Independent Director
- 559.79K
- Suketu Upadhyay
- Independent Director
- 544.66K
- Diana L. McKenzie
- Independent Director
- 553.11K
- Michel Lagarde
- Independent Director
- 449.08K
- Dr. Alan M. Garber, M.D.,PhD
- Independent Director
- 537.63K
- Bruce I. Sachs
- Lead Independent Director
- 600.04K
- Dr. Jennifer Schneider, M.D.
- Independent Director
- --
- Dr. Sangeeta N. Bhatia, PhD
- Independent Director
- 550.31K
- Nancy A. Thornberry
- Independent Director
- 407.65K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
